Brown Capital Management LLC Ironwood Pharmaceuticals Inc Transaction History

Brown Capital Management LLC

$4.56 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$5.58 - $8.61 $668,651 - $1.03 Million	-119,830 Reduced 4.44%	2,580,875 $16.8 Million
Q1 2024 May 15, 2024	SELL	$8.32 - $15.45 $8.39 Million - $15.6 Million	-1,008,726 Reduced 27.19%	2,700,705 $23.5 Million
Q4 2023 Feb 14, 2024	SELL	$8.79 - $11.51 $91,108 - $119,301	-10,365 Reduced 0.28%	3,709,431 $42.4 Million
Q3 2023 Nov 14, 2023	SELL	$8.25 - $11.35 $262,366 - $360,952	-31,802 Reduced 0.85%	3,719,796 $35.8 Million
Q2 2023 Aug 14, 2023	SELL	$10.1 - $11.6 $1.84 Million - $2.12 Million	-182,335 Reduced 4.63%	3,751,598 $39.9 Million
Q1 2023 May 15, 2023	SELL	$10.37 - $12.56 $654,471 - $792,686	-63,112 Reduced 1.58%	3,933,933 $41.4 Million
Q4 2022 Feb 14, 2023	SELL	$9.9 - $12.43 $45.9 Million - $57.7 Million	-4,640,073 Reduced 53.72%	3,997,045 $49.5 Million
Q3 2022 Nov 14, 2022	SELL	$10.14 - $12.38 $30.5 Million - $37.2 Million	-3,004,817 Reduced 25.81%	8,637,118 $89.5 Million
Q2 2022 Aug 15, 2022	SELL	$11.05 - $12.72 $28.6 Million - $32.9 Million	-2,587,064 Reduced 18.18%	11,641,935 $134 Million
Q1 2022 May 16, 2022	SELL	$10.61 - $12.88 $21.5 Million - $26.1 Million	-2,028,900 Reduced 12.48%	14,228,999 $179 Million
Q4 2021 Feb 14, 2022	SELL	$10.86 - $13.95 $8.11 Million - $10.4 Million	-746,496 Reduced 4.39%	16,257,899 $190 Million
Q3 2021 Nov 15, 2021	SELL	$11.92 - $13.92 $17.6 Million - $20.6 Million	-1,480,364 Reduced 8.01%	17,004,395 $222 Million
Q2 2021 Aug 16, 2021	SELL	$10.16 - $13.11 $17.1 Million - $22.1 Million	-1,685,367 Reduced 8.36%	18,484,759 $238 Million
Q1 2021 May 14, 2021	BUY	$9.04 - $11.86 $177,753 - $233,203	19,663 Added 0.1%	20,170,126 $226 Million
Q4 2020 Feb 16, 2021	BUY	$9.05 - $12.2 $426,897 - $575,486	47,171 Added 0.23%	20,150,463 $230 Million
Q3 2020 Nov 13, 2020	BUY	$8.99 - $10.74 $11.7 Million - $14 Million	1,305,231 Added 6.94%	20,103,292 $181 Million
Q2 2020 Aug 07, 2020	BUY	$9.14 - $11.97 $7.65 Million - $10 Million	837,212 Added 4.66%	18,798,061 $194 Million
Q1 2020 May 08, 2020	BUY	$8.58 - $14.01 $513,049 - $837,741	59,796 Added 0.33%	17,960,849 $181 Million
Q4 2019 Feb 14, 2020	SELL	$8.22 - $14.0 $244,364 - $416,192	-29,728 Reduced 0.17%	17,901,053 $238 Million
Q3 2019 Nov 13, 2019	BUY	$8.59 - $10.96 $48.1 Million - $61.4 Million	5,600,891 Added 45.43%	17,930,781 $154 Million
Q2 2019 Aug 13, 2019	BUY	$9.8 - $12.89 $19.6 Million - $25.8 Million	2,003,252 Added 19.4%	12,329,890 $135 Million
Q1 2019 May 15, 2019	BUY	$8.27 - $12.73 $1.63 Million - $2.51 Million	197,307 Added 1.95%	10,326,638 $140 Million
Q4 2018 Feb 14, 2019	BUY	$7.8 - $16.13 $28.7 Million - $59.4 Million	3,679,820 Added 57.06%	10,129,331 $105 Million
Q3 2018 Nov 14, 2018	BUY	$14.31 - $17.65 $2.06 Million - $2.54 Million	144,055 Added 2.28%	6,449,511 $119 Million
Q2 2018 Aug 14, 2018	BUY	$11.83 - $16.2 $480,664 - $658,222	40,631 Added 0.65%	6,305,456 $121 Million
Q1 2018 May 15, 2018	BUY	$11.13 - $13.63 $11,130 - $13,630	1,000 Added 0.02%	6,264,825 $96.7 Million
Q4 2017 Feb 14, 2018	BUY	$12.16 - $14.58 $562,400 - $674,325	46,250 Added 0.74%	6,263,825 $93.9 Million
Q3 2017 Nov 14, 2017	BUY	$12.07 - $14.87 $75 Million - $92.5 Million	6,217,575	6,217,575 $98.1 Million

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

Black Rock Inc. New York, NY

22.9M
Shares

$80.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

22M
Shares

$77.8 Million
0.0% of portfolio
Sarissa Capital Management LP Greenwich, CT

16.4M
Shares

$57.9 Million
16.75% of portfolio
Pacer Advisors, Inc. Malvern, PA

11.3M
Shares

$39.8 Million
0.11% of portfolio
State Street Corp Boston, MA

9.92M
Shares

$35 Million
0.0% of portfolio

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $541M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brown Capital Management LLC with notifications on news.

Account